C4 Therapeutics Correlations

CCCC Stock

USD 2.12 0.07 3.20%

The correlation of C4 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

C4 Therapeutics Correlation With Market

Very weak diversification

The correlation between C4 Therapeutics and DJI is 0.55 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in C4 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.

Moving together with CCCC Stock

0.71	EYEN	Eyenovia	Pair Corr
0.82	MOLN	Molecular Partners	Pair Corr
0.81	SNDL	SNDL Inc	Pair Corr
0.89	CLDX	Celldex Therapeutics	Pair Corr
0.73	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.71	CRVS	Corvus Pharmaceuticals	Pair Corr
0.66	ELMD	Electromed	Pair Corr
0.86	GKOS	Glaukos Corp	Pair Corr
0.8	ITGR	Integer Holdings Corp	Pair Corr
0.87	LIVN	LivaNova PLC	Pair Corr
0.63	MDAI	Spectral AI	Pair Corr
0.92	MODD	Modular Medical	Pair Corr
0.89	APYX	Apyx Medical	Pair Corr
0.73	SGHT	Sight Sciences	Pair Corr
0.92	SRDX	SurModics	Pair Corr
0.88	CNMD	CONMED	Pair Corr

Moving against CCCC Stock

0.91	CMRX	Chimerix	Pair Corr
0.83	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.75	FNA	Paragon 28	Pair Corr
0.84	LUCD	Lucid Diagnostics	Pair Corr
0.78	NVRO	Nevro Corp	Pair Corr
0.7	LUNG	Pulmonx Corp	Pair Corr
0.66	INMD	InMode	Pair Corr
0.45	NYXH	Nyxoah	Pair Corr
0.9	BRK-A	Berkshire Hathaway	Pair Corr
0.9	BRK-B	Berkshire Hathaway	Pair Corr
0.82	NHNCF	NAVER Corp	Pair Corr
0.77	FWEDF	Fireweed Zinc	Pair Corr
0.68	PKX	POSCO Holdings	Pair Corr
0.65	TRGGF	Tarachi Gold Corp	Pair Corr

Related Correlations Analysis

	STTK	ELYM	PRLD	GLUE	FHTX	CYT	RZLT	IPSC	EWTX	MLYS
STTK		0.0	-0.17	-0.21	0.16	0.0	-0.03	-0.32	-0.36	-0.24	STTK
ELYM	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ELYM
PRLD	-0.17	0.0		0.14	-0.14	0.0	0.81	0.6	0.25	-0.17	PRLD
GLUE	-0.21	0.0	0.14		0.43	0.0	0.05	0.44	0.45	0.5	GLUE
FHTX	0.16	0.0	-0.14	0.43		0.0	0.02	0.18	0.05	-0.08	FHTX
CYT	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	CYT
RZLT	-0.03	0.0	0.81	0.05	0.02	0.0		0.52	0.25	-0.51	RZLT
IPSC	-0.32	0.0	0.6	0.44	0.18	0.0	0.52		0.52	-0.02	IPSC
EWTX	-0.36	0.0	0.25	0.45	0.05	0.0	0.25	0.52		0.02	EWTX
MLYS	-0.24	0.0	-0.17	0.5	-0.08	0.0	-0.51	-0.02	0.02		MLYS
	STTK	ELYM	PRLD	GLUE	FHTX	CYT	RZLT	IPSC	EWTX	MLYS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RZLT	+ 0.81	PRLD
IPSC	+ 0.6	PRLD
IPSC	+ 0.52	RZLT
EWTX	+ 0.52	IPSC
MLYS	+ 0.5	GLUE
EWTX	+ 0.45	GLUE

High negative correlations

MLYS	- 0.51	RZLT
EWTX	- 0.36	STTK
IPSC	- 0.32	STTK
MLYS	- 0.24	STTK
GLUE	- 0.21	STTK
MLYS	- 0.17	PRLD

Risk-Adjusted Indicators

There is a big difference between CCCC Stock performing well and C4 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze C4 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STTK	5.20	0.25	0.04	0.29	6.38	(6.57)	11.21	(7.58)	50.15
ELYM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PRLD	5.56	(0.01)	0.00	(0.09)	0.00	0.00	12.50	(9.70)	61.66
GLUE	3.30	0.02	0.00	(0.06)	0.00	0.00	7.34	(7.40)	19.92
FHTX	3.79	(0.25)	0.00	(0.19)	0.00	0.00	9.05	(8.30)	26.22
CYT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
RZLT	3.07	(0.47)	0.00	(0.57)	0.00	0.00	5.62	(6.55)	22.04
IPSC	2.92	(1.21)	0.00	36.47	0.00	0.00	5.88	(7.48)	17.02
EWTX	2.94	(0.08)	0.00	(0.13)	0.00	0.00	5.32	(7.61)	26.44
MLYS	4.32	0.58	0.16	(0.42)	4.22	(5.10)	10.04	(8.23)	50.53

C4 Therapeutics Corporate Management

Paige Mahaney	Chief Officer	Profile
Kelly Schick	Chief Officer	Profile
Isabel Chiu	Senior Development	Profile
Mr MBA	Chief Officer	Profile
Andrew Hirsch	Pres CEO	Profile
Leonard MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC